13 completed. 13 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). I-131-1095, Enzalutamide - Metastatic Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | Completed | Progenics Pharmaceuticals, Inc. | 120 | 2019-05-30 | 2025-10-14 |
| Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. Estetrol, Placebo Oral Tablet - Prostatic Neoplasm | Phase 2 | Completed | Pantarhei Oncology B.V. | 63 | 2018-04-16 | 2021-06-18 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 30 | 2018-02-16 | 2024-07-12 |
| 68Ga PSMA in Preprostatectomy Patients Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 22 | 2018-02-16 | 2024-02-15 |
| Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study Perflutren Lipid Microsphere Intravenous Suspension - Prostatic Neoplasm | Phase 2 | Completed | Thomas Jefferson University | 55 | 2017-02-01 | 2025-04-30 |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer sipuleucel-T, leuprolide acetate - Prostatic Neoplasm, Prostate Cancer | Phase 2 | Completed | Dendreon | 68 | 2011-09-01 | 2017-05-30 |
| IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen abiraterone acetate in combination with prednisone - Prostate Cancer, Prostatic Neoplasm | Phase 2 | Completed | Janssen Biotech, Inc. | 131 | 2011-05-04 | 2026-02-24 |
| Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer radioimmuniguided intenstiy modulated radiotherapy - Prostatic Neoplasm | Phase 1 / Phase 2 | Completed | Mayo Clinic | 72 | 2006-10-01 | 2011-02-25 |
| Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer SR31747A - Prostatic Neoplasm | Phase 2 | Completed | Sanofi | 232 | 2003-10-01 | 2008-12-23 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy STI571 (GlivecĀ®) - Prostatic Neoplasm, Genital Neoplasms, Male | Phase 2 | Completed | Novartis Pharmaceuticals | 51 | 2003-06-01 | 2017-06-01 |
| Preop Conformal Radiotherapy - Prostate Pre-Operative Conformal Radiotherapy - Prostatic Neoplasm | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 15 | 2000-05-01 | 2010-08-11 |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer thalidomide - Prostatic Neoplasm | Phase 2 | Completed | National Cancer Institute (NCI) | 64 | 1995-09-01 | 2008-03-04 |
| A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma Suramin - Prostatic Neoplasm | Phase 2 | Completed | National Cancer Institute (NCI) | 70 | 1990-10-01 | 2008-03-04 |
Prostatic Neoplasms (13) · Genital Neoplasms, Male (2) · Neoplasms (2) · Prostatic Diseases (2) · Prostatic Neoplasms, Castration-Resistant (2) · Urogenital Neoplasms (2) · Abdominal Neoplasms (1) · Adenocarcinoma (1) · Carcinoma (1) · Genital Diseases, Male (1) · Hot Flashes (1) · Neoplasms, Glandular and Epithelial (1)
Genital Diseases (13) · Male Urogenital Diseases (13) · Neoplasms by Site (13) · Urogenital Diseases (13) · Genital Diseases, Male (12) · Genital Neoplasms, Male (11) · Neoplasms (11) · Prostatic Diseases (11) · Urogenital Neoplasms (11) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms by Histologic Type (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Abiraterone Acetate (1) · Estetrol (1) · Imatinib Mesylate (1) · Leuprolide (1) · Prednisone (1) · Suramin (1) · Thalidomide (1) · enzalutamide (1) · luprolide acetate gel depot (1) · perflutren (1) · sipuleucel-T (1)
Michael Graham PhD, MD (2) · National Cancer Institute (NCI) (2) · Dendreon (1) · Janssen Biotech, Inc. (1) · Mayo Clinic (1) · Novartis Pharmaceuticals (1) · Pantarhei Oncology B.V. (1) · Progenics Pharmaceuticals, Inc. (1) · Sanofi (1) · Thomas Jefferson University (1) · University Health Network, Toronto (1)
United States (9) · Canada (3) · Netherlands (2) · Australia (1) · Belgium (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Mexico (1) · Poland (1) · Portugal (1) · Spain (1) · United Kingdom (1)
Ethan J Halpern, MD (1) · Flemming Forsberg, PhD (1) · Jean-Claude Provost, MD (1) · Michael Graham, MD, PhD (1) · Michael M. Graham, MD, PhD (1) · Padraig Warde, MD (1) · Robert Israel, MD (1)
R21CA202214 (1)